Page last updated: 2024-11-05

pirinixic acid and Dermatitis, Atopic

pirinixic acid has been researched along with Dermatitis, Atopic in 3 studies

pirinixic acid: structure

Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatano, Y1
Elias, PM1
Crumrine, D1
Feingold, KR1
Katagiri, K1
Fujiwara, S1
Chiba, T1
Takeuchi, S1
Esaki, H1
Yamamura, K1
Kurihara, Y1
Moroi, Y1
Furue, M1
Staumont-Sallé, D1
Abboud, G1
Brénuchon, C1
Kanda, A1
Roumier, T1
Lavogiez, C1
Fleury, S1
Rémy, P1
Papin, JP1
Bertrand-Michel, J1
Tercé, F1
Staels, B1
Delaporte, E1
Capron, M1
Dombrowicz, D1

Other Studies

3 other studies available for pirinixic acid and Dermatitis, Atopic

ArticleYear
Efficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis.
    The Journal of investigative dermatology, 2011, Volume: 131, Issue:9

    Topics: Adjuvants, Immunologic; Animals; Clobetasol; Dermatitis, Atopic; Disease Models, Animal; Drug Synerg

2011
Topical application of PPARα (but not β/δ or γ) suppresses atopic dermatitis in NC/Nga mice.
    Allergy, 2012, Volume: 67, Issue:7

    Topics: Animals; Dermatitis, Atopic; Disease Models, Animal; Eosinophils; Epidermis; Female; Immunoglobulin

2012
Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis.
    The Journal of allergy and clinical immunology, 2008, Volume: 121, Issue:4

    Topics: Administration, Cutaneous; Administration, Topical; Adult; Animals; Bronchial Hyperreactivity; Derma

2008